Bolder BioPATH, Inc. is a contract pharmacology and pathology company specializing in In Vivo models of Rheumatoid Arthritis, Osteoarthritis, and Inflammatory Bowel Disease as well as other autoimmune and inflammation models. Our goals are to provide preclinical (efficacy and toxicity) data to support advancing proteins and small molecules to IND/NDA stage.
DDW Tracks Basic Science, Microbiome in Gastrointestinal and Liver Diseases, Inflammatory Bowel Diseases, Liver Diseases and Transplantation, Obesity and Nutrition, Esophageal Diseases, Stomach and Small Bowel Disorders, Colorectal Diseases, Functional GI and Motility Disorders, Pancreatic Diseases, Biliary Tract Diseases, Pediatric GI
Does your company only service US attendees? No
Is your company a new exhibiting company? Yes